92 related articles for article (PubMed ID: 16444053)
1. [Humoral mechanisms of autoimmune process against type I collagen in psoriasis].
Kaladze RA; Gogebashvili NV
Georgian Med News; 2005 Dec; (129):132-4. PubMed ID: 16444053
[TBL] [Abstract][Full Text] [Related]
2. Detection of psoriasin/S100A7 in the sera of patients with psoriasis.
Anderson KS; Wong J; Polyak K; Aronzon D; Enerbäck C
Br J Dermatol; 2009 Feb; 160(2):325-32. PubMed ID: 19016707
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against type XVII collagen C-terminal domain in a patient with bullous pemphigoid associated with psoriasis vulgaris.
Inokuma D; Kodama K; Natsuga K; Kasai M; Abe M; Nishie W; Abe R; Hashimoto T; Shimizu H
Br J Dermatol; 2009 Feb; 160(2):451-4. PubMed ID: 19077079
[No Abstract] [Full Text] [Related]
4. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis.
Koivula MK; Aman S; Alasaarela E; Karjalainen A; Hakala M; Risteli J
Rheumatology (Oxford); 2006 Nov; 45(11):1364-9. PubMed ID: 16632481
[TBL] [Abstract][Full Text] [Related]
5. [Alexithymia and psoriasis: a case-control study of 53 patients].
Masmoudi J; Maalej I; Masmoudi A; Rached H; Rebai A; Turki H; Jaoua A
Encephale; 2009 Feb; 35(1):10-7. PubMed ID: 19250988
[TBL] [Abstract][Full Text] [Related]
6. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN
Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
8. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients.
Mulyowa GK; Jaeger G; Kabakyenga J; Bröcker EB; Zillikens D; Schmidt E
Int J Dermatol; 2006 Sep; 45(9):1047-52. PubMed ID: 16961507
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
[TBL] [Abstract][Full Text] [Related]
11. [Frequency of celiac disease among patients with psoriasis].
Calderón H P; Valdés A P; Zemelman D V; Poniachik T J; Hurtado H C; Garmendia M ML; Abumohor G P; Echavarri P MC
Rev Med Chil; 2007 Oct; 135(10):1296-303. PubMed ID: 18180837
[TBL] [Abstract][Full Text] [Related]
12. Is there an association between antiphospholipid antibodies and psoriasis?
Cassano N; Buquicchio R; Ranieri V; Loconsole F; Vena GA
J Biol Regul Homeost Agents; 2008; 22(3):207-10. PubMed ID: 18842175
[TBL] [Abstract][Full Text] [Related]
13. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
14. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
Makredes M; Robinson D; Bala M; Kimball AB
J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
16. [Changes of ultrastructure and p-53 protein expression on the peripheral blood lymphocytes of patients with vulgar form of psoriasis after balneal therapy in resort "nunisi"].
Rukhadze L; Tsagareli Z; Gogiashvili L; Nebolsina L; Gudjabidze R
Georgian Med News; 2005 May; (122):76-80. PubMed ID: 15988091
[TBL] [Abstract][Full Text] [Related]
17. An investigation of antistreptococcal antibody responses in guttate psoriasis.
Nahary L; Tamarkin A; Kayam N; Sela S; Fry L; Baker B; Powles A; Rogers S; Benhar I
Arch Dermatol Res; 2008 Sep; 300(8):441-9. PubMed ID: 18648827
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial.
Mittal R; Malhotra S; Pandhi P; Kaur I; Dogra S
Arch Dermatol; 2009 Apr; 145(4):387-93. PubMed ID: 19380660
[TBL] [Abstract][Full Text] [Related]
19. [IgE-autoantibodies in patients with atopic dermatitis].
Gervazieva VB; Samoĭlikov PV; Sveranovskaia VV
Patol Fiziol Eksp Ter; 2009; (1):19-22. PubMed ID: 19382619
[TBL] [Abstract][Full Text] [Related]
20. [Transforming growth factor beta, metalloproteinase 2 and its tissue inhibitor 2 in the serum from patients with early and late boreliosis].
Pancewicz SA; Izycka A; Klibingat M; Zajkowska JM; Swierzbińska-Pijanowska R; Kondrusik M; Grygorczuk SS; Izycki T; Hermanowska-Szpakowicz T
Pol Merkur Lekarski; 2008 Dec; 25(150):495-9. PubMed ID: 19205380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
